One Stage Ridge Splitting Using 2 Different Techniques in the Posterior Mandible
Launched by CAIRO UNIVERSITY · Mar 17, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
-The selected patients will be informed of the nature of the research work and informed consent will be obtained then randomized in equal proportions between, control group ridge splitting with simultaneous implants using the conventional technique and study group ridge splitting with simultaneous implants using the piezo surgery.
* Pre operative procedures Patients of both groups will be subjected to CBCT (diagnostic for upper arch), Diagnostic wax-up and stent fabrication.
* Intra operative procedures (for both groups) followed by CBCT will be taken for every patient after 4 months.
* Sc...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with mandibular residual alveolar bone height not less than 8 mm.
- • Alveolar bone width from 5mm to 3mm.
- • Both genders.
- • At least single missing tooth.
- • Previous failed implants.
- • Tapered or cylinder cross sectioned alveolar bone defect pattern.
- Exclusion Criteria:
- • Heavy smokers more than 20 cigarettes per day.
- • Patients with bone disease that may affect normal healing, example; hyperparathyroidism.
- • Patients had radiotherapy and chemotherapy in head and neck.
- • Patients had neoplasms in sites to be grafted.
- • Patients with Metabolic diseases uncontrolled diabetic patients, Glycated hemoglobin (Hb A1c) more than 7 mg\\dl.
- • Pregnant females.
- • Patients with Para functional habits, apprehensive and non-cooperative.
- • Bone pathology related to the site to be grafted.
- • Psychological problems, stress situation (socially or professionally), emotional instability, and unrealistic patients' expectations.
- • Intraoral soft and hard tissue pathology.
- • Systemic condition that contraindicates implant placement.
- • Under the age of 18 years.
- • Hourglass defects or defects with bone concavities and or undercuts.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported